PCSK9: a promising therapeutic target for dyslipidemias?

This publication has 28 references indexed in Scilit:

• The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits
  Published by Elsevier ,2005
• Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia
  Human Mutation, 2005
• What Promise Does PCSK9Hold?
  Journal of the American College of Cardiology, 2005
• Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia
  Human Molecular Genetics, 2005
• LDL-receptor mutations in Europe
  Human Mutation, 2004
• Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia
  Clinical Genetics, 2004
• A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree
  Human Genetics, 2004
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003
• The Cholesterol Quartet
  Science, 2001